1. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
- Author
-
Raphael Jeker, Rebecca Higgins, Thomas Daikeler, Olivier Bignucolo, Anne-Valérie Burgener, Annemarie Gabrysch, Benedikt J. Meyer, Annaïse Jauch, Christoph Hess, Jan-Olaf Gebbers, Matthias Mehling, Alexander A. Navarini, Fabian Baldin, Bodo Grimbacher, Charlotte Schwab, Anne Kistner, Petr Hruz, Fabian Meienberg, Ingmar Heijnen, Barbara-Christina Padberg Sgier, Florian Marquardsen, David M. Sansom, Lukas T. Jeker, Marc B. Bigler, Olle Kämpe, Mike Recher, Christoph Berger, Natalie Frede, and Tie Zheng Hou
- Subjects
0301 basic medicine ,Enterocolitis ,biology ,business.industry ,Immunology ,Vedolizumab ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,CTLA-4 ,030220 oncology & carcinogenesis ,Mutation (genetic algorithm) ,Monoclonal ,medicine ,biology.protein ,Immunology and Allergy ,Missense mutation ,Antibody ,medicine.symptom ,business ,medicine.drug - Published
- 2017
- Full Text
- View/download PDF